Logo image of SUUN

POWERBANK CORP (SUUN) Stock Fundamental Analysis

NASDAQ:SUUN - Nasdaq - CA83417Y1088 - Common Stock - Currency: USD

1.36  +0.05 (+3.82%)

After market: 1.3697 +0.01 (+0.71%)

Fundamental Rating

2

Overall SUUN gets a fundamental rating of 2 out of 10. We evaluated SUUN against 49 industry peers in the Construction & Engineering industry. SUUN has a bad profitability rating. Also its financial health evaluation is rather negative. SUUN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SUUN has reported negative net income.
SUUN had a negative operating cash flow in the past year.
SUUN Yearly Net Income VS EBIT VS OCF VS FCFSUUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

SUUN has a worse Return On Assets (-7.79%) than 79.59% of its industry peers.
SUUN has a Return On Equity of -29.18%. This is in the lower half of the industry: SUUN underperforms 77.55% of its industry peers.
Industry RankSector Rank
ROA -7.79%
ROE -29.18%
ROIC N/A
ROA(3y)-0.64%
ROA(5y)N/A
ROE(3y)-3.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SUUN Yearly ROA, ROE, ROICSUUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Gross Margin, with a value of 19.44%, SUUN is in line with its industry, outperforming 57.14% of the companies in the same industry.
SUUN's Gross Margin has declined in the last couple of years.
SUUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5YN/A
SUUN Yearly Profit, Operating, Gross MarginsSUUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

SUUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SUUN has more shares outstanding
SUUN has a worse debt/assets ratio than last year.
SUUN Yearly Shares OutstandingSUUN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
SUUN Yearly Total Debt VS Total AssetsSUUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SUUN has an Altman-Z score of 0.31. This is a bad value and indicates that SUUN is not financially healthy and even has some risk of bankruptcy.
SUUN has a Altman-Z score of 0.31. This is amonst the worse of the industry: SUUN underperforms 81.63% of its industry peers.
A Debt/Equity ratio of 1.37 is on the high side and indicates that SUUN has dependencies on debt financing.
SUUN's Debt to Equity ratio of 1.37 is on the low side compared to the rest of the industry. SUUN is outperformed by 63.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.31
ROIC/WACCN/A
WACC9.73%
SUUN Yearly LT Debt VS Equity VS FCFSUUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

SUUN has a Current Ratio of 1.13. This is a normal value and indicates that SUUN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, SUUN is doing worse than 67.35% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SUUN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, SUUN is doing worse than 73.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.94
SUUN Yearly Current Assets VS Current LiabilitesSUUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

SUUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -695.41%.
The Revenue for SUUN has decreased by -37.83% in the past year. This is quite bad
SUUN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 99.55% yearly.
EPS 1Y (TTM)-695.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-302.45%
Revenue 1Y (TTM)-37.83%
Revenue growth 3Y99.55%
Revenue growth 5YN/A
Sales Q2Q%-62.6%

3.2 Future

The Earnings Per Share is expected to grow by 98.16% on average over the next years. This is a very strong growth
SUUN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.61% yearly.
EPS Next Y143.64%
EPS Next 2Y137.79%
EPS Next 3Y98.16%
EPS Next 5YN/A
Revenue Next Year23.21%
Revenue Next 2Y34.22%
Revenue Next 3Y30.61%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SUUN Yearly Revenue VS EstimatesSUUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
SUUN Yearly EPS VS EstimatesSUUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SUUN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 5.47, the valuation of SUUN can be described as very cheap.
SUUN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SUUN is cheaper than 100.00% of the companies in the same industry.
SUUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.47
SUUN Price Earnings VS Forward Price EarningsSUUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SUUN Per share dataSUUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

SUUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SUUN's earnings are expected to grow with 98.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y137.79%
EPS Next 3Y98.16%

More info and screens

0

5. Dividend

5.1 Amount

SUUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POWERBANK CORP

NASDAQ:SUUN (8/8/2025, 8:08:00 PM)

After market: 1.3697 +0.01 (+0.71%)

1.36

+0.05 (+3.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)09-29 2025-09-29
Inst Owners8.32%
Inst Owner ChangeN/A
Ins Owners15.13%
Ins Owner ChangeN/A
Market Cap48.08M
Analysts82.22
Price Target4.77 (250.74%)
Short Float %1.22%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-419.75%
Min EPS beat(2)-792.45%
Max EPS beat(2)-47.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-52.92%
Min Revenue beat(2)-75.57%
Max Revenue beat(2)-30.27%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.45%
EPS NQ rev (1m)-509.6%
EPS NQ rev (3m)-126.3%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-9.37%
Revenue NQ rev (3m)-25.63%
Revenue NY rev (1m)-22.32%
Revenue NY rev (3m)-22.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.47
P/S 1.78
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)0.25
Fwd EY18.28%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.76
BVpS1.07
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.79%
ROE -29.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.44%
FCFM N/A
ROA(3y)-0.64%
ROA(5y)N/A
ROE(3y)-3.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5YN/A
F-Score1
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 294.78%
Cap/Sales 38.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.94
Altman-Z 0.31
F-Score1
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)1403.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.48%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-695.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-302.45%
EPS Next Y143.64%
EPS Next 2Y137.79%
EPS Next 3Y98.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.83%
Revenue growth 3Y99.55%
Revenue growth 5YN/A
Sales Q2Q%-62.6%
Revenue Next Year23.21%
Revenue Next 2Y34.22%
Revenue Next 3Y30.61%
Revenue Next 5YN/A
EBIT growth 1Y-469.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year551.32%
EBIT Next 3Y414.37%
EBIT Next 5YN/A
FCF growth 1Y-40.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y254.89%
OCF growth 3YN/A
OCF growth 5YN/A